CD4 and Its Relevance to Advanced Glycation End Products in Tuberculosis Patients with Co-morbidity Diabetes

BACKGROUND: Tuberculosis (TB) is one of the most common infectious diseases found in developing countries. One of the risk factors for TB is diabetes, a chronic metabolic disorder characterised by hyperglycemia. The altered in glucose metabolism will cause dysfunction of phagocyte and antibacterial...

Descripción completa

Detalles Bibliográficos
Autores principales: Widjaja, Sry Suryani, Rusdiana, Savira, Maya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2018
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290417/
https://www.ncbi.nlm.nih.gov/pubmed/30559871
http://dx.doi.org/10.3889/oamjms.2018.347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290417/
https://www.ncbi.nlm.nih.gov/pubmed/30559871
http://dx.doi.org/10.3889/oamjms.2018.347

Ejemplares similares